Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | HTT | P42858 | 4/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 7/20 | 0.43 |
| ▸ | CNR2 | P34972 | 7/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.40 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.39 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.39 |
| ▸ | RARB | P10826 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29352274 | 0.89 | ALDH1A1 (0.54) | ALDH1A1HTTSMN1; SMN2TP53GAA | |
| SCHEMBL13214162 | 0.89 | ALDH1A1 (0.54) | ALDH1A1HTTSMN1; SMN2TP53GAA | |
| SCHEMBL22916111 | 0.89 | ALDH1A1 (0.54) | ALDH1A1HTTSMN1; SMN2TP53GAA | |
| SCHEMBL25560742 | 0.85 | ALDH1A1 (0.49) | ALDH1A1HTTSMN1; SMN2TP53GAA | |
| SCHEMBL29349816 | 0.81 | ALDH1A1 (0.55) | ALDH1A1HTTSMN1; SMN2TP53GAA | |
| SCHEMBL13214160 | 0.81 | ALDH1A1 (0.55) | ALDH1A1HTTSMN1; SMN2TP53GAA | |
| SCHEMBL16079756 | 0.80 | ALDH1A1 (0.51) | ALDH1A1HTTSMN1; SMN2TP53GAA | |
| SCHEMBL25561086 | 0.78 | ALDH1A1 (0.41) | ALDH1A1HTTSMN1; SMN2TP53GAA | |
| SCHEMBL23008681 | 0.71 | ALDH1A1 (0.52) | ALDH1A1HTTSMN1; SMN2TP53GAA | |
| SCHEMBL9767995 | 0.70 | PPARA (0.77) | ALDH1A1TP53PPARAKAT8RARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11707444-B2 | Antiviral composition for SARS-CoV-2 containing cannabinoids as active ingredient | RESEARCH COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY (KR) | 2023-07-25 | — | — | US | disclosed |
| US-11707444-B2 | Antiviral composition for SARS-CoV-2 containing cannabinoids as active ingredient | RESEARCH COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY (KR) | 2023-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11707444-B2 | Antiviral composition for SARS-CoV-2 containing cannabinoids as active ingredient | TMPRSS2, ACE2, CNR2 | ALDH1A1 3986/4885HTT 2111/4885SMN1; SMN2 3282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.